Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome

Nevin Yusufova, Matthew R Teater, PhD, Alexey Soshnev, Andreas Kloetgen, Adewola Osunsade, Joseph Conway, Ashley Doane, Arthur Skoultchi, Aristotelis Tsirigos, PhD, Yael David, C. David Allis, PhD, Ethel Cesarman, MD PhD, Ari Melnick, MD

Blood (2019) 134 (Supplement_1): 23.

https://doi.org/10.1182/blood-2019-127774

Published: 2019

Journal Articles

Computational Systems Biology Models for the Identification of Metabolic Vulnerabilities in Multiple Myeloma

Luis Vitores V. Valcárcel, MSc, Raquel Ordoñez, PhD, Iñigo Apaolaza, MSc, Ana Valcárcel, Leire Garate, Cem Meydan, PhD, Bruno Paiva, PhD, Ari M Melnick, MD, Jesús San-Miguel, Francisco J. Planes, Xabier Agirre, PhD, Felipe Prosper, MD PhD

Blood (2019) 134 (Supplement_1): 3084.

https://doi.org/10.1182/blood-2019-123970

Published: 2019

Journal Articles

Characterization of Complete Lncrnas Transcriptome Reveals Expression of Lncrnas As a Prognostic Factor and Linc-Smilo As a Potential Therapeutic Target in Multiple Myeloma

Blood (2019) 134 (Supplement_1): 4323.

https://doi.org/10.1182/blood-2019-123008

Published: 2019

Journal Articles

Lncrnas As New Partners of Novel Chimeric Transcripts in Multiple Myeloma

Ane Amundarain, Luis Vitores Valcárcel, MSc, Raquel Ordoñez, PhD, Leire Garate, Estíbaliz Miranda, Xabier Cendoya, Maria Jose Calasanz, PhD BSc, Bruno Paiva, PhD, Jesús San-Miguel, Francisco J Planes, Felipe Prósper, MD PhD, Xabier Agirre, PhD

Blood (2019) 134 (Supplement_1): 4356.

https://doi.org/10.1182/blood-2019-122568

Published: 2019

Journal Articles

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Thierry Fest, Fabienne Desmots-Loyer, Mikael Roussel, MD PhD, Celine Pangault, PhD, Cedric Pastoret, MD, Francisco Llamas-Gutierrez, Eric Guiheneuf, Valérie Camara-clayette, Thierry Lamy, Pr, MD PhD, Karin Tarte, PhD, Vincent Ribrag, MD

Blood (2018) 132 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2018-99-113269

Published: 2018

Journal Articles

Therapeutic Targeting of HDAC3 in FOXO1-Mutant DLBCL

Kristy Stengel, PhD, Srividya Bhaskara, PhD, Jing Wang, PhD, Qi Liu, PhD, Scott Hiebert, PhD

Blood (2017) 130 (Supplement 1): 311.

https://doi.org/10.1182/blood.V130.Suppl_1.311.311

Published: 2017

Journal Articles

Two Variants of Follicular Lymphoma Grade 3

Lyubov V. Plastinina, Alla M. Kovrigina, MD PhD, Sergey K. Kravchenko, MD PhD, Tatiana N. Obukhova, MD PhD, Ekaterina S. Nesterova, MD PhD, Aminat U. Magomedova, MD PhD, Yana K. Mangasarova, MD PhD, Anna E. Misyurina, PhD MD, Fatima Babayeva, Sergei M. Kulikov, PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5161.

https://doi.org/10.1182/blood.V130.Suppl_1.5161.5161

Published: 2017

Journal Articles

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

Blood (2017) 130 (Supplement 1): 39.

https://doi.org/10.1182/blood.V130.Suppl_1.39.39

Published: 2017

Journal Articles

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Thomas Yssing Michaelsen, BS, Rasmus Froberg Brøndum, Senior Bioinformatician, Julia Richter, PhD, Wolfram Klapper, MD, Mads Albertsen, Associate Professor, Hans Erik Johnsen, MD Professor, Karen Dybkær, Professor, Tarec Christoffer El-Galaly, MD PhD, Martin Bøgsted, Professor

Blood (2017) 130 (Supplement 1): 3995.

https://doi.org/10.1182/blood.V130.Suppl_1.3995.3995

Published: 2017

Journal Articles

Outcomes of Grade 3A Follicular Lymphoma: Best Treated As Aggressive or Indolent Lymphoma?

Narendranath Epperla, MD, Timothy S. Fenske, MD, Horatiu Olteanu, MD PhD, Julie Pruett, APNP, Areyl Goff, APNP, Katie Zellner, PA-C, Mehdi Hamadani, MD, Nirav N. Shah, MD MSHP

Blood (2016) 128 (22): 5328.

https://doi.org/10.1182/blood.V128.22.5328.5328

Published: 2016

Journal Articles

Clinical, Biological Characteristics and Outcome of Pediatric Follicular Lymphoma at Children's Cancer Hospital - Egypt: A Single Center Experience

Shaimaa Samir Eissa, MD PhD, Samah Fathy Semary, MD, Asmaa Salama, MD, Alaa M Elhaddad, MD PhD

Blood (2016) 128 (22): 5343.

https://doi.org/10.1182/blood.V128.22.5343.5343

Published: 2016

Journal Articles

MYC-ID3 Pathway in a Cohort of Diffuse Large B Cell Lymphomas: Immunoistochemical Analysis and Prognostic Implications

Elisa Doni, MD, Fabio Pagni, MD, Fausto Rossini, MD, Angelo Belotti, MD, Silvia Bolis, MD, Ivana Casaroli, MD, Giorgio Cattoretti, MD, Pietro Enrico Pioltelli, MD, Carlo Gambacorti-Passerini, MD

Blood (2016) 128 (22): 5310.

https://doi.org/10.1182/blood.V128.22.5310.5310

Published: 2016

Journal Articles

High Expression of CXCR4 Impairs Anti-CD20 Monoclonal Antibody (Rituximab)-Dependent Cytotoxicity in Diffuse Large B-Cell Lymphoma

Linn Rønlev Reinholdt, PhDStudent, Maria Bach Laursen, PhD, Steffen Falgreen, PhD, Alexander Schmitz, Dr. rer. nat., Julie Støve Bødker, PhD, Martin Boegsted, Professor MSO, Hans Erik Johnsen, Professor, MD, Karen Dybkaer, Professor MSO

Blood (2015) 126 (23): 1455.

https://doi.org/10.1182/blood.V126.23.1455.1455

Published: 2015

Journal Articles

Tumor Vs Normal Gene Expression Profiles Identify Deregulated Pathways in ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia: A Microarray-Based Meta-Analysis

Thomas Heiden, PhD, Janette Nickel, Robert Preissner, PhD, Karl Seeger, Prof. PhD

Blood (2015) 126 (23): 4812.

https://doi.org/10.1182/blood.V126.23.4812.4812

Published: 2015

Journal Articles

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Blood (2014) 124 (21): 2973.

https://doi.org/10.1182/blood.V124.21.2973.2973

Published: 2014

Journal Articles

Long-Term Remissions Of Patients With Follicular Lymphoma Grade 3 Treated With Rituximab, Cyclophospamide, Doxorubicine, Vincristine and Prednisone (R-CHOP)

Paolo Strati, MD, Jorge Enrique Romaguera, MD, Larry W. Kwak, MD, PhD, Fredrick B Hagemeister, MD, Maria Alma Rodriguez, MD, Yasuhiro Oki, MD, Jason R. Westin, MD, Francesco Turturro, MD, Michael J. Overman, MD, Sattva S. Neelapu, MD, Nathan Fowler, MD, Luis Fayad, MD

Blood (2013) 122 (21): 3028.

https://doi.org/10.1182/blood.V122.21.3028.3028

Published: 2013

Journal Articles

Iterative Germinal Center Re-Entries of Memory B-Cells with t(14;18) Translocation and Early Steps of Follicular Lymphoma Progression

Sandrine Roulland, PhD, Jocelyne Stephanie Sungalee, Ester Morgado, Emilie Mamessier, Emilie Gregoire, Celine Monvoisin, Cedric Menard, Jean-Marc Navarro, Franziska C. Eberle, Philippe Ruminy, Elaine S. Jaffe, MD, Claudine Schiff, Jean Hardwigsen, Karin Tarte, Bertrand Nadel, PhD

Blood (2012) 120 (21): 150.

https://doi.org/10.1182/blood.V120.21.150.150

Published: 2012

Journal Articles

NEK2 Regulates Immature B Cell Development and GC Formation in NEK2 Transgenic Mouse

Wen Zhou, PhD, Xiao He, He Wang, Mohamed E Salama, M.D., Xia Jiliang, Hongwei Xu, MD, MS, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD

Blood (2012) 120 (21): 257.

https://doi.org/10.1182/blood.V120.21.257.257

Published: 2012

Journal Articles

Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab

Björn Engelbrekt Wahlin, MD, PhD, Christer Sundström, Harald Holte, Birgitta Sander, MD, Ph.D., Bjørn Østenstad, Peter de Nully Brown, Erlend B. Smeland, Jan Delabie, Birger Christensson, M.D., Ph.D., Eva Kimby, M.D., Ph.D.

Blood (2011) 118 (21): 1641.

https://doi.org/10.1182/blood.V118.21.1641.1641

Published: 2011

Journal Articles

The BRAF V600E Mutation in Hairy Cell Leukemia and Other Mature B-Cell Neoplasms

Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Roberta Riboni, Sara Rattotti, Marzia Varettoni, Maria Luisa Guerrera, Marco Lucioni, Annamaria Tenore, Michele Merli, Silvia Rizzi, Lucia Morello, Chiara Cavalloni, Marco Paulli, Mario Cazzola

Blood (2011) 118 (21): 262.

https://doi.org/10.1182/blood.V118.21.262.262

Published: 2011

NARROW

Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome

Computational Systems Biology Models for the Identification of Metabolic Vulnerabilities in Multiple Myeloma

Characterization of Complete Lncrnas Transcriptome Reveals Expression of Lncrnas As a Prognostic Factor and Linc-Smilo As a Potential Therapeutic Target in Multiple Myeloma

Lncrnas As New Partners of Novel Chimeric Transcripts in Multiple Myeloma

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Therapeutic Targeting of HDAC3 in FOXO1-Mutant DLBCL

Two Variants of Follicular Lymphoma Grade 3

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Outcomes of Grade 3A Follicular Lymphoma: Best Treated As Aggressive or Indolent Lymphoma?

Clinical, Biological Characteristics and Outcome of Pediatric Follicular Lymphoma at Children's Cancer Hospital - Egypt: A Single Center Experience

MYC-ID3 Pathway in a Cohort of Diffuse Large B Cell Lymphomas: Immunoistochemical Analysis and Prognostic Implications

High Expression of CXCR4 Impairs Anti-CD20 Monoclonal Antibody (Rituximab)-Dependent Cytotoxicity in Diffuse Large B-Cell Lymphoma

Tumor Vs Normal Gene Expression Profiles Identify Deregulated Pathways in ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia: A Microarray-Based Meta-Analysis

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Long-Term Remissions Of Patients With Follicular Lymphoma Grade 3 Treated With Rituximab, Cyclophospamide, Doxorubicine, Vincristine and Prednisone (R-CHOP)

Iterative Germinal Center Re-Entries of Memory B-Cells with t(14;18) Translocation and Early Steps of Follicular Lymphoma Progression

NEK2 Regulates Immature B Cell Development and GC Formation in NEK2 Transgenic Mouse

Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab

The BRAF V600E Mutation in Hairy Cell Leukemia and Other Mature B-Cell Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only